The Genetic Link

Welcome to The Genetic Link, a blog providing new insights into DNA and RNA sample collection by DNA Genotek. DNA Genotek is a subsidiary of OraSure Technologies, Inc.

All Posts

Article by: Katherine Lawless

Phosphorus: Stretching the Capabilities of Clinical-Grade Genetic Testing 


“Our mission is to extend and improve lives by making genomics a foundational part of everyone’s health and wellness journey.” - Alexander Bisignano.   

Alexander Bisignano’s early passion for science and biology led him on an exciting journey to becoming the CEO of Phosphorus, a company with a ground-breaking approach to medical-grade genetic testing.   


Recently, Alexander and his co-founder launched GeneCompass, a preventative consumer-genetic test, powered by Next Generation Sequencing (NGS) technology to examine more than 400 genes. The test leverages DNA Genotek’s Oragene•Dxat-home, self-collection saliva devices to collect high-quality DNA samples in order to detect more than 200 health risks, over 200 genetic drug interactions, and uncover insights into more than 40 wellness attributes.  


Alexander’s idea finds its origins in the rising global popularity of genetic testing, among healthcare professionals, academics, researchers, and lately consumers. Advances in genetic-sequencing technologies have paved the way for adapted diagnostic as well as therapeutic health services; and have improved patients’ and individuals’ health outcomes through personalized health.     


Alexander and his co-founder wanted to deliver a genetic-testing service that focuses primarily on providing the technology, infrastructure, and expertise to drive healthcare care initiatives. They established a CLIA-certified* laboratory, in New Jersey, that allows patients and their physicians to utilize genetic testing for diagnostic and therapeutic purposes.    


In the most recent episode of our Podcast, Molecules, Microbes, and Multiomics, we invited Alexander Bisignano to tell us more about his company’s application of genetic testing and to share what is in store for them in the future.    

We hope you enjoy the conversation!  


*CLIA stands for Clinical Laboratory Improvement Amendments  


Learn more about Oragene.Dx Request free trial kits 

Learn more about Phosphorus' Genomic Platform

Subscribe and Get Our Latest Posts

Type Your Email Address

Recent Posts

Highlights from the 2023 European Society of Human Genetics conference

Like last year, this year’s annual European Society of Human Genetics (ESHG) conference was a hybrid even...
Sanna Abbasi, PhD Jul 18, 2023 4:22:54 PM

A faster and more affordable path to FDA clearance

When developing a clinical or diagnostic test or assay for patient use, a strong indicator of device effe...
Sanna Abbasi, PhD, and Jayden Hess Jul 10, 2023 11:51:00 AM

Revisiting the Saliva and Liquid Sampling Australia 2023 conference

From May 31st to June 2nd, 2023, the fourth Saliva and Liquid Australia (SALSA) conference was held both ...
Sanna Abbasi, PhD Jul 5, 2023 10:39:13 AM